CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-03 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −3,400,000 | $1.42 | $4.8M | 5,875,851 |
| 2025-03-04 | Brady Todd C President and CEO | Grant or award · Stock Option (right to buy) | +809,710 | 809,710 | ||
| 2025-03-04 | Machatha Stephen Chief Development Officer | Grant or award · Stock Option (right to buy) | +202,427 | 202,427 | ||
| 2024-08-12 | Machatha Stephen Chief Development Officer | Sale | −16,041 | $4.74 | $76K | 236,771 |
| 2024-08-12 | Greenberg Bruce See Remarks | Sale | −10,834 | $4.74 | $51K | 126,382 |
| 2024-06-10 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +3,860 | 3,860 | ||
| 2024-06-04 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +40,282 | 40,282 | ||
| 2024-06-04 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +10,418 | 10,418 | ||
| 2024-06-04 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +1,215 | 1,215 | ||
| 2024-06-04 | JOYCE MARTIN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +40,282 | 40,282 | ||
| 2024-06-04 | JOYCE MARTIN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +1,215 | 1,215 | ||
| 2024-06-04 | JOYCE MARTIN JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +5,209 | 5,209 | ||
| 2024-06-04 | Walker Neal Director | Grant or award · Stock Option (Right to Buy) | +40,282 | 40,282 | ||
| 2024-06-04 | Walker Neal Director | Grant or award · Stock Option (Right to Buy) | +1,736 | 1,736 | ||
| 2024-06-04 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +40,282 | 40,282 | ||
| 2024-06-04 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +1,736 | 1,736 | ||
| 2024-06-04 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +40,282 | 40,282 | ||
| 2024-06-04 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +2,604 | 2,604 | ||
| 2024-06-04 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +2,778 | 2,778 | ||
| 2024-06-04 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +40,282 | 40,282 |
Page 3 of 19 · 376 trades